ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 810

Sexual Dysfunction in Women with Systemic Sclerosis

Marina Soledad Dalpiaz1, Juan Argüello2, Maria Florencia Rodriguez3, Marta Mamani4, Anastasia Secco5, Natalia Tamborenea2, Eduardo Kerzberg6, Sandra Fabiana Montoya6, Carolina Aimo6, Fernando Manuel Villalobos6, Eliana Rebeca Serrano7, Maria Elena Crespo Espindola8 and Ana Lía Gervilla Galan9, 1Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina, 2Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Reumatologia, Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina, 4Rheumatology Department, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 5Rheumatology Section, Hospital Bernardino Rivadavia, CABA, Argentina, 6Hospital General de Agudos José María Ramos Mejía, BUENOS AIRES, Argentina, 7Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 8Reumatologia, Hospital Señor del Milagro, Salta, Argentina, 9Hospital San Roque, San Salvador de Jujuy, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Impaired sexual function is common among women with chronic illnesses, including Systemic Sclerosis (SSc). Studies of sexual functioning among women with SSc have concluded that sexual impairment is common, according to comparisons with both the general population and women with other chronic diseases. There are no studies in our country that evaluate the impact of SSc in this area.

Objectives: To evaluate sexual impairment in women with SSc. To investigate sociodemographic, disease characteristics and psychological variables associated with sexual impairment in women with SSc.

Methods: Observational, analytical, cross-sectional study. We included women between 20 and 59 years of age diagnosed with SSc according to 2013 American college of rheumatology/European league against rheumatism classification criteria, from 5 public rheumatology centers of Argentina, between April 2017 and April 2018. We excluded patients with severe chronic diseases or other autoimmune rheumatologic diseases. Sexual impairment was assessed using the spanish version of Female Sexual Function Index (FSFI) questionnaire, which has been validated among latin american women aged 20 to 59 years. Higher subscale or total scores indicate better sexual function. A cutoff score of 26.55 is proposed as a criterion for impaired sexual function. We used Hospital Anxiety and Depression Scale (HADS) questionnaire to evaluate anxiety and depression. For the descriptive analysis, the continuous variables were reported as mean and standard deviation or median and interquartile range (IQR). The categorical variables were reported as percentage. A multiple linear regression model was performed, taking sexual dysfunction as the dependent variable, adjusted for possible confounders. The performance of the model was evaluated (assumptions, atypical observations, multicollinearity).

Results: We included 46 patients. The mean age was 44.78 years (+/- 9.84) and 39.13% were postmenopausal women. The mean FSFI score was 21.07 (+/- 8). Eighty percent presented sexual dysfunction and 13.04% of them correspond to sexually inactive patients due to the disease. The variables that showed significantly association with sexual dysfunction in the univariate analysis were: dyspnea (β coefficient: -2.91. CI 95%: -5.79 to -0.04), VAS pain (β coefficient: -0.08. CI 95%: -0.15 to -0.005), VAS fatigue (β coefficient: -0.09. CI 95%: -0.17 to -0.01), body image satisfaction (β coefficient: 4.34. CI 95%: 0.80 to 7.88), age (β coefficient: -0.28. CI 95%: -0.51 to -0.05) and fibromyalgia (β coefficient: -14.73. CI 95%: -21.99 to -7.47). The variables that showed significantly and independent association in the multivariate analysis were: body image satisfaction (β coefficient: 4.11. CI 95%: 1.10 to 7.13), age (β coefficient: -0.25. CI 95%: -0.45 to -0.05), fibromyalgia (β coefficient: -11.37. CI 95%: -18.26 to -4.48).

Conclusion: We found that sexual dysfunction is frequent between women with Systemic Sclerosis, and that is in concordance with other studies. According with our results, patients with greater body image satisfaction, younger and without fibromyalgia had better sexual function.


Disclosure: M. S. Dalpiaz, None; J. Argüello, None; M. F. Rodriguez, None; M. Mamani, None; A. Secco, None; N. Tamborenea, None; E. Kerzberg, None; S. F. Montoya, None; C. Aimo, None; F. M. Villalobos, None; E. R. Serrano, None; M. E. Crespo Espindola, None; A. L. Gervilla Galan, None.

To cite this abstract in AMA style:

Dalpiaz MS, Argüello J, Rodriguez MF, Mamani M, Secco A, Tamborenea N, Kerzberg E, Montoya SF, Aimo C, Villalobos FM, Serrano ER, Crespo Espindola ME, Gervilla Galan AL. Sexual Dysfunction in Women with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/sexual-dysfunction-in-women-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sexual-dysfunction-in-women-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology